SynCardia Nearly Doubles Sales for Second Straight Year in 2011

Posted on January 4th, 2012

SynCardia Systems, manufacturer of the only total artificial heart approved by regulatory agencies in the U.S., Canada and Europe, announces that sales have nearly doubled for the second straight year. Sales in 2010 doubled over 2009. SynCardia ended 2011 as another double. 2012 is projected as a break-out year.

2012 1-04 – SynCardia Nearly Doubles Sales for Second Straight Year in 2011

About Anthem Equity Group

Anthem is an open-integrated company where our investors, lenders, vendors and team members are part of a seamless organization, committed to working together to maximize our returns in a climate of opportunity and uncertainty. Today’s modern communication tools form the platform for this strategy.